Homoeopathic Management in a Case of Infertility with PCOS

2021 ◽  
Author(s):  
Padmalaya Rath ◽  
Shweta Gautam
Keyword(s):  
Ovarian Function ◽  
Polycystic Ovary ◽  
Sexually Active ◽  
Polycystic Ovaries ◽  
Ovary Syndrome ◽  
Menstrual Cycles ◽  
The Past ◽  
Irregular Menses ◽  
Anovulatory Infertility ◽  
Androgen Levels

AbstractInfertility is the inability of a sexually active couple, not using any birth control, to get pregnant after 1 year of trying. About one-quarter of female infertility is caused by a problem with ovulation. Polycystic ovary syndrome (PCOS) accounts for more than 75% of cases of anovulatory infertility. PCOS is a disorder of chronically abnormal ovarian function and hyperandrogenism (abnormally elevated androgen levels) manifested by irregular menstrual cycles, polycystic ovaries, excess unwanted hair, obesity etc. A case of a female aged 21 years with irregular menses for the past 2 years diagnosed with PCOS and inability to conceive has been reported here. The case was worked out as per homoeopathic principles and individualised homoeopathic medicine, Pulsatilla nigricans (Puls. nig.) was prescribed and the patient responded positively and conceived

scholarly journals Polycystic Ovaries and Polycystic Ovary Syndrome in Epilepsy: Evidence for Neurogonadal Disease

2005 ◽  
Vol 5 (4) ◽  
pp. 142-146 ◽  
Author(s):  
Cynthia L. Harden
Keyword(s):  
Weight Gain ◽  
Adverse Effects ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Moving Target ◽  
Polycystic Ovaries ◽  
Ovary Syndrome ◽  
Reproductive Disorder ◽  
Underlying Causes ◽  
Androgen Levels

Polycystic ovary syndrome (PCOS) is a mysterious reproductive disorder that results in subfertility. The underlying causes are not known, and even the definition is a moving target. Women with epilepsy have features of PCOS at a higher than expected rate, and polycystic ovaries (PCO) also are present at high rates in this population. Valproate is associated with weight gain and increased androgen levels, two features of PCOS. This review proposes that epilepsy, with its known adverse effects on luteinizing hormone pulsatility, could be a cause of PCOS and that valproate could be an imitator, if not also a cause of the syndrome.

scholarly journals MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome

2017 ◽  
Vol 176 (2) ◽  
pp. R53-R65 ◽  
Author(s):  
Dorte Glintborg ◽  
Marianne Andersen
Keyword(s):  
Insulin Resistance ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Premenopausal Women ◽  
Polycystic Ovaries ◽  
Ovary Syndrome ◽  
Vitamin D Levels ◽  
Irregular Menses ◽  
Long Term Prognosis

Polycystic ovary syndrome (PCOS) is the most prevalent endocrine condition in premenopausal women. The syndrome is characterized by hyperandrogenism, irregular menses and polycystic ovaries when other etiologies are excluded. Obesity, insulin resistance and low vitamin D levels are present in more than 50% patients with PCOS, these factors along with hyperandrogenism could have adverse effects on long-term health. Hyperinflammation and impaired epithelial function were reported to a larger extent in women with PCOS and could particularly be associated with hyperandrogenism, obesity and insulin resistance. Available data from register-based and data linkage studies support that metabolic-vascular and thyroid diseases, asthma, migraine, depression and cancer are diagnosed more frequently in PCOS, whereas fracture risk is decreased. Drug prescriptions are significantly more common in PCOS than controls within all diagnose categories including antibiotics. The causal relationship between PCOS and autoimmune disease represents an interesting new area of research. PCOS is a lifelong condition and long-term morbidity could be worsened by obesity, sedentary way of life, Western-style diet and smoking, whereas lifestyle intervention including weight loss may partly or fully resolve the symptoms of PCOS and could improve the long-term prognosis. In this review, the possible implications of increased morbidity for the clinical and biochemical evaluation of patients with PCOS at diagnosis and follow-up is further discussed along with possible modifying effects of medical treatment.

scholarly journals Use of Inositols in Polycystic Ovary Syndrome

2020 ◽  
Vol 16 (28) ◽  
pp. 24-34
Author(s):  
O.A. Pustotina ◽  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Ovarian Function ◽  
Polycystic Ovary ◽  
The Body ◽  
Metabolic Parameters ◽  
Ovary Syndrome ◽  
Pathogenetic Role

The article presents key data on the physiology of inositols in the body, their pathogenetic role in the development of polycystic ovary syndrome, and the possibilities of myo-inositol and D-chiro-inositol in the restoration of ovarian function, metabolic parameters, and overcoming of infertility.

Sign in / Sign up

Export Citation Format

Share Document